Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8 T Cell Response
In this communication, we demonstrate that galectin (Gal)-9 acts to constrain CD8+ T cell immunity to Herpes Simplex Virus (HSV) infection. In support of this, we show that animals unable to produce Gal-9, because of gene knockout, develop acute and memory responses to HSV that are of greater magnitude and better quality than those that occur in normal infected animals. Interestingly, infusion of normal infected mice with α-lactose, the sugar that binds to the carbohydrate-binding domain of Gal-9 limiting its engagement of T cell immunoglobulin and mucin (TIM-3) receptors, also caused a more elevated and higher quality CD8+ T cell response to HSV particularly in the acute phase. Such sugar treated infected mice also had expanded populations of effector as well as memory CD8+ T cells. The increased effector T cell responses led to significantly more efficient virus control. The mechanisms responsible for the outcome of the Gal-9/TIM-3 interaction in normal infected mice involved direct inhibitory effects on TIM-3+ CD8+ T effector cells as well as the promotion of Foxp3+ regulatory T cell activity. Our results indicate that manipulating galectin signals, as can be achieved using appropriate sugars, may represent a convenient and inexpensive approach to enhance acute and memory responses to a virus infection.
Vyšlo v časopise:
Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8 T Cell Response. PLoS Pathog 6(5): e32767. doi:10.1371/journal.ppat.1000882
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000882
Souhrn
In this communication, we demonstrate that galectin (Gal)-9 acts to constrain CD8+ T cell immunity to Herpes Simplex Virus (HSV) infection. In support of this, we show that animals unable to produce Gal-9, because of gene knockout, develop acute and memory responses to HSV that are of greater magnitude and better quality than those that occur in normal infected animals. Interestingly, infusion of normal infected mice with α-lactose, the sugar that binds to the carbohydrate-binding domain of Gal-9 limiting its engagement of T cell immunoglobulin and mucin (TIM-3) receptors, also caused a more elevated and higher quality CD8+ T cell response to HSV particularly in the acute phase. Such sugar treated infected mice also had expanded populations of effector as well as memory CD8+ T cells. The increased effector T cell responses led to significantly more efficient virus control. The mechanisms responsible for the outcome of the Gal-9/TIM-3 interaction in normal infected mice involved direct inhibitory effects on TIM-3+ CD8+ T effector cells as well as the promotion of Foxp3+ regulatory T cell activity. Our results indicate that manipulating galectin signals, as can be achieved using appropriate sugars, may represent a convenient and inexpensive approach to enhance acute and memory responses to a virus infection.
Zdroje
1. ZinkernagelRM
1996 Immunology taught by viruses. Science 271 173 178
2. AhmedR
GrayD
1996 Immunological memory and protective immunity: understanding their relation. Science 272 54 60
3. GandhiRT
WalkerBD
2002 Immunologic control of HIV-1. Annu Rev Med 53 149 172
4. RabinovichGA
ToscanoMA
2009 Turning ‘sweet’ on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 9 338 352
5. MercierS
St-PierreC
PelletierI
OuelletM
TremblayMJ
2008 Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption. Virology 371 121 129
6. OuelletM
MercierS
PelletierI
BounouS
RoyJ
2005 Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells. J Immunol 174 4120 4126
7. KuchrooVK
DardalhonV
XiaoS
AndersonAC
2008 New roles for TIM family members in immune regulation. Nat Rev Immunol 8 577 580
8. SehrawatS
SuryawanshiA
HirashimaM
RouseBT
2009 Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J Immunol 182 3191 3201
9. ChabotS
KashioY
SekiM
ShiratoY
NakamuraK
2002 Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 12 111 118
10. BonneauRH
JenningsSR
1989 Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity. J Virol 63 1480 1484
11. ColesRM
MuellerSN
HeathWR
CarboneFR
BrooksAG
2002 Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J Immunol 168 834 838
12. SmithPM
WolcottRM
ChervenakR
JenningsSR
1994 Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma). Virology 202 76 88
13. WallaceME
KeatingR
HeathWR
CarboneFR
1999 The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J Virol 73 7619 7626
14. GangappaS
DeshpandeSP
RouseBT
1999 Bystander activation of CD4(+) T cells can represent an exclusive means of immunopathology in a virus infection. Eur J Immunol 29 3674 3682
15. GairinJE
MazarguilH
HudrisierD
OldstoneMB
1995 Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J Virol 69 2297 2305
16. ZhuC
AndersonAC
SchubartA
XiongH
ImitolaJ
2005 The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6 1245 1252
17. KoopmanG
ReutelingspergerCP
KuijtenGA
KeehnenRM
PalsST
1994 Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84 1415 1420
18. SederRA
DarrahPA
RoedererM
2008 T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8 247 258
19. SuvasS
KumaraguruU
PackCD
LeeS
RouseBT
2003 CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 198 889 901
20. DittmerU
HeH
MesserRJ
SchimmerS
OlbrichAR
2004 Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 20 293 303
21. SekiM
OomizuS
SakataKM
SakataA
ArikawaT
2008 Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127 78 88
22. JonesRB
NdhlovuLC
BarbourJD
ShethPM
JhaAR
2008 Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 205 2763 2779
23. Golden-MasonL
PalmerBE
KassamN
Townshend-BulsonL
LivingstonS
2009 Negative Immune Regulator Tim-3 Is Overexpressed in Hepatitis C Infection and Its Blockade Rescues Dysfunctional Cd4+ and Cd8+ T Cells. J Virol
24. KuchrooVK
MeyersJH
UmetsuDT
DeKruyffRH
2006 TIM family of genes in immunity and tolerance. Adv Immunol 91 227 249
25. ThomasJ
RouseBT
1998 Immunopathology of herpetic stromal keratitis: discordance in CD4+ T cell function between euthymic host and reconstituted SCID recipients. J Immunol 160 3965 3970
26. AndersonAC
AndersonDE
BregoliL
HastingsWD
KassamN
2007 Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318 1141 1143
27. ZhengY
ChaudhryA
KasA
deRoosP
KimJM
2009 Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458 351 356
28. KochMA
Tucker-HeardG
PerdueNR
KillebrewJR
UrdahlKB
2009 The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10 595 602
29. ChaudhryA
RudraD
TreutingP
SamsteinRM
LiangY
2009 CD4+ Regulatory T Cells Control TH17 Responses in a Stat3-Dependent Manner. Science
30. NagaharaK
ArikawaT
OomizuS
KontaniK
NobumotoA
2008 Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J Immunol 181 7660 7669
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 5
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Quorum Sensing Inhibition Selects for Virulence and Cooperation in
- The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis
- Susceptibility to Anthrax Lethal Toxin-Induced Rat Death Is Controlled by a Single Chromosome 10 Locus That Includes
- Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species